Melatonin Agb Pharma

Melatonin, the active ingredient in Melatonin Agb Pharma, is a melatonin receptor agonist presented as an oral dosage for oral use. It is employed to help regulate the sleep‑wake cycle in adults experiencing insomnia, circadian rhythm disturbances, or jet‑lag related sleep disruption.

GNH USA supplies Melatonin Agb Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides reliable sourcing for global healthcare providers.

Melatonin Agb Pharma is a melatonin receptor agonist used to address disorders of the sleep‑wake cycle. - Insomnia: helps reduce sleep onset latency and improve total sleep time in individuals with difficulty falling or staying asleep. - Sleep‑wake rhythm disorders: assists in synchronising abnormal circadian patterns such as delayed sleep phase syndrome. - Jet lag: facilitates adaptation to new time zones by advancing or delaying the internal clock.

Adverse reactions to melatonin are generally mild, but some users may experience more serious events.

Common Side Effects: - Drowsiness or daytime sleepiness - Headache - Dizziness - Nausea

Serious or Rare Side Effects: - Allergic reactions such as rash, itching, or swelling - Mood changes including depression or agitation (rare)

When considering melatonin therapy, several safety aspects should be reviewed. - Use in children: limit use to pediatric guidance and monitor for behavioral changes. - Concomitant CNS depressants: avoid excessive sedation when combined with alcohol or sedative medications. - Chronic medical conditions: assess renal or hepatic impairment before initiating therapy. - Pregnancy and lactation: consult a healthcare professional as safety data are limited. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and light.

Melatonin may interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): melatonin may enhance anticoagulant effect, increasing bleeding risk. - Immunosuppressants (e.g., cyclosporine): potential alteration of drug metabolism leading to reduced efficacy.

Moderate Interactions (Monitor Closely): - CNS depressants (benzodiazepines, antihistamines): may increase sedation. - Oral contraceptives: melatonin could affect hormone levels, requiring monitoring. - Antidiabetic agents: possible influence on glucose control, necessitating blood‑sugar monitoring.